| 2025 | Comparison of Remimazolam-Based Monitored Anesthesia Care and Inhalation-Based General Anesthesia in Transurethral Resection of Bladder Tumor: A Randomized-Controlled Trial
| CANCERS |
| 2025 | Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2024 | Evaluation of the Diagnostic Efficacy of the AI-Based Software INF-M01 in Detecting Suspicious Areas of Bladder Cancer Using Cystoscopy Images
| JOURNAL OF CLINICAL MEDICINE |
| 2024 | Risk factors for urinary retention after robot-assisted radical cystectomy with orthotopic neobladder diversion: a multicenter study
| JOURNAL OF ROBOTIC SURGERY |
| 2024 | Incidence and Pattern of Recurrence after Surgical Resection in Organ-Confined Renal Cell Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2024 | Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2024 | The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer
| CANCERS |
| 2024 | The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): study protocol for a multi-center, prospective, randomized trial
| TRIALS |
| 2024 | Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer
| FRONTIERS IN ONCOLOGY |
| 2024 | Preoperative smoking and robot-assisted radical cystectomy outcomes & complications in multicenter KORARC database
| SCIENTIFIC REPORTS |
| 2024 | ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy | CANCER SCIENCE |
| 2024 | Clinical Validation of the Proenkephalin (PENK) Methylation Urine Test for Monitoring Recurrence of Non-muscle-invasive Bladder Cancer
| EUROPEAN UROLOGY OPEN SCIENCE |
| 2024 | Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study | EUROPEAN UROLOGY FOCUS |
| 2024 | Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2024 | PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma
| CANCER CELL INTERNATIONAL |
| 2023 | Differences in clinical features between focal and extensive types of cystitis glandularis in patients without a previous history of urinary tract malignancy
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2023 | Toward Precision Medicine: Development and Validation of A Machine Learning Based Decision Support System for Optimal Sequencing in Castration-Resistant Prostate Cancer | CLINICAL GENITOURINARY CANCER |
| 2023 | Outcomes of single-port robotic ureteral reconstruction using the da Vinci SP® system
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2023 | Exploring the Characteristics of Circulating Tumor DNA in Pt1a Clear Cell Renal Cell Carcinoma: A Pilot Study
| CANCERS |
| 2023 | Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey
| Korean Journal of Urological Oncology(대한비뇨기종양학술지) |
| 2023 | External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study | INTERNATIONAL JOURNAL OF UROLOGY |
| 2022 | Intravesical Recurrence after Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma Is Associated with Flexible Diagnostic Ureteroscopy, but Not with Rigid Diagnostic Ureteroscopy
| CANCERS |
| 2022 | Characteristics of BRCA2 Mutated Prostate Cancer at Presentation
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2022 | Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy: Multicenter KORARC database study | INTERNATIONAL JOURNAL OF UROLOGY |
| 2022 | Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies
| BIOMEDICINES |
| 2022 | Warm ischemia time length during on-clamp partial nephrectomy: does it really matter? | MINERVA UROLOGY AND NEPHROLOGY |
| 2022 | Evaluation of the Surgical Margin Threshold for Avoiding Recurrence after Partial Nephrectomy in Patients with Renal Cell Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2022 | Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers
| BIOMEDICINES |
| 2022 | Gender-related outcomes in robot-assisted radical cystectomy: A multi-institutional study
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2022 | Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment
| BIOMEDICINES |
| 2021 | Metabolic tumour volume on 18 F-FDG PET/CT predicts extended pathological T stages in patients with renal cell carcinoma at staging
| SCIENTIFIC REPORTS |
| 2021 | Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype
| PROSTATE CANCER AND PROSTATIC DISEASES |
| 2021 | Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma
| CANCER RESEARCH AND TREATMENT |
| 2021 | Oncologic Outcomes of Intracorporeal vs Extracorporeal Urinary Diversion After Robot-Assisted Radical Cystectomy: A Multi-Institutional Korean Study | JOURNAL OF ENDOUROLOGY |
| 2021 | Prognostic value of prostate volume in non-muscle invasive bladder cancer
| SCIENTIFIC REPORTS |
| 2021 | Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer
| SCIENTIFIC REPORTS |
| 2021 | Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
| YONSEI MEDICAL JOURNAL |
| 2021 | Effect of intraoperative fluid volume on postoperative ileus after robot-assisted radical cystectomy
| SCIENTIFIC REPORTS |
| 2021 | Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging
| CANCERS |
| 2021 | The DEAD/DEAH Box Helicase, DDX11, Is Essential for the Survival of Advanced Clear Cell Renal Cell Carcinoma and Is a Determinant of PARP Inhibitor Sensitivity
| CANCERS |
| 2021 | Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases | ANNALS OF SURGICAL ONCOLOGY |
| 2021 | Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model
| BIOLOGY OPEN |
| 2021 | Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial
| CANCER & METABOLISM |
| 2021 | Oncological outcome according to attainment of pentafecta after robot-assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database | BJU INTERNATIONAL |
| 2020 | Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma
| CANCERS |
| 2020 | Retzius-sparing robot-assisted radical prostatectomy versus open retropubic radical prostatectomy: a prospective comparative study with 19-month follow-up | MINERVA UROLOGICA E NEFROLOGICA |
| 2020 | Perioperative immunotherapy in muscle-invasive bladder cancer
| TRANSLATIONAL CANCER RESEARCH |
| 2020 | Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study
| FRONTIERS IN ONCOLOGY |
| 2020 | Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma
| DIAGNOSTICS |
| 2020 | Muscle Characteristics Obtained Using Computed Tomography as Prognosticators in Patients with Castration-Resistant Prostate Cancer
| CANCERS |
http://orcid.org/0000-0003-2246-8838
(23097952400)
